BREAKING: Handl Health has just secured a groundbreaking $14.2 million in Series A funding to revolutionize the healthcare intelligence sector. The funding, led by Arthur Ventures, aims to combat surging insurance costs through innovative AI technology, making this an urgent development for companies grappling with skyrocketing healthcare premiums.
Located in Culver City, Handl Health’s new capital will accelerate the deployment of its AI-powered platform, which enhances how clients navigate traditional and alternative health insurance. “We had the fortune of good timing with legislation around healthcare transparency,” said CEO Ahmed Marmoush. “For example, a colonoscopy could cost anywhere from $350 to $3,500.”
The demand is evident—over the past year, Handl Health has experienced a staggering 300% increase in revenue. This surge is fueled by mid- to large-sized companies eager to mitigate healthcare costs, a pressing concern for the 164.5 million Americans under retirement age who rely on employer-sponsored health plans.
Handl Health’s approach equips businesses with advanced tools that allow for precise cost comparisons and system enhancements for insurance brokers and third-party administrators. Co-founder Ria Shah oversees operations and data science, ensuring the platform remains at the forefront of healthcare delivery.
Handl also participated in the Cedars-Sinai Accelerator program in 2023, which provided mentorship and funding for companies focused on improving patient care. This strategic partnership has positioned Handl Health to leverage national data and adapt to changing healthcare landscapes effectively.
As healthcare costs continue to rise, Handl Health’s innovations could significantly impact both businesses and consumers. Experts anticipate that their tools will improve transparency and drive competition among providers, ultimately benefiting patients.
Stay tuned for more updates as Handl Health embarks on this transformative journey in the healthcare sector. The implications of this funding round are poised to affect millions of Americans and could reshape the future of health insurance.
